Clinical Chemistry, Malmö
941 – 950 of 1294
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
(
- Contribution to journal › Article
-
Mark
Diagnosing protein S deficiency: analytical considerations.
(
- Contribution to journal › Article
-
Mark
Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.
(
- Contribution to journal › Article
-
Mark
Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)
(
- Contribution to journal › Article
-
Mark
Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women.
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance (FVLeiden) and thrombosis: factor V mutations causing hypercoagulable states
(
- Contribution to journal › Scientific review
-
Mark
Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
(
- Contribution to journal › Article
-
Mark
Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation.
(
- Contribution to journal › Article
-
Mark
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening
(
- Contribution to journal › Article
-
Mark
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen
(
- Contribution to journal › Article